[Effectiveness and safety of sofosbuvir+daclatasvir in the treatment of chronic hepatitis C virus infection in Yan'an, Shaanxi].
作者信息
Gao X H, Jing P
机构信息
Department of Infectious Diseases, Affiliated Hospital of Yan'an University, Yan'an 716000, China.
出版信息
Zhonghua Gan Zang Bing Za Zhi. 2019 Jun 20;27(6):457-459. doi: 10.3760/cma.j.issn.1007-3418.2019.06.013.
Abstract
摘要
相似文献
1
[Effectiveness and safety of sofosbuvir+daclatasvir in the treatment of chronic hepatitis C virus infection in Yan'an, Shaanxi].索磷布韦+达卡他韦治疗陕西省延安市慢性丙型肝炎病毒感染的有效性和安全性
Zhonghua Gan Zang Bing Za Zhi. 2019 Jun 20;27(6):457-459. doi: 10.3760/cma.j.issn.1007-3418.2019.06.013.
2
Efficacy and safety of sofosbuvir and daclatasvir in treatment of kidney transplantation recipients with hepatitis C virus infection.索磷布韦和达卡他韦治疗肾移植受者丙型肝炎病毒感染的疗效和安全性。
World J Gastroenterol. 2017 Aug 28;23(32):5969-5976. doi: 10.3748/wjg.v23.i32.5969.
3
Daclatasvir and Sofosbuvir Versus Sofosbuvir and Ribavirin in Patients with Chronic Hepatitis C Coinfected with HIV: A Matching-adjusted Indirect Comparison.在合并感染HIV的慢性丙型肝炎患者中，达卡他韦与索磷布韦联合用药对比索磷布韦与利巴韦林联合用药：一项匹配调整间接比较研究
Clin Ther. 2016 Feb;38(2):404-12. doi: 10.1016/j.clinthera.2015.12.017. Epub 2016 Feb 3.
4
Generic sofosbuvir-based direct-acting antivirals in hepatitis C virus-infected patients with chronic kidney disease.索磷布韦为基础的通用直接作用抗病毒药物治疗慢性肾脏病合并丙型肝炎病毒感染患者。
Liver Int. 2018 Dec;38(12):2137-2148. doi: 10.1111/liv.13863. Epub 2018 May 14.
5
'Real-life' experience with direct-acting antiviral agents for hepatitis C virus in end-stage renal disease.终末期肾病患者使用丙型肝炎病毒直接抗病毒药物的“真实世界”经验。
Int J Artif Organs. 2018 Jul;41(7):363-370. doi: 10.1177/0391398818763478. Epub 2018 Mar 27.
6
Successful treatment of chronic hepatitis C infection with directly acting antivirals in renal transplant recipients.肾移植受者使用直接作用抗病毒药物成功治疗慢性丙型肝炎感染。
Nephrology (Carlton). 2018 Sep;23(9):876-882. doi: 10.1111/nep.13109.
7
Treatment of chronic hepatitis C viral infection with sofosbuvir and daclatasvir in kidney transplant recipients.索磷布韦和达卡他韦用于肾移植受者慢性丙型肝炎病毒感染的治疗
Transpl Infect Dis. 2019 Feb;21(1):e13018. doi: 10.1111/tid.13018. Epub 2018 Nov 22.
8
Daclatasvir: A Review in Chronic Hepatitis C.达卡他韦：慢性丙型肝炎治疗药物评价。
Drugs. 2016 Sep;76(14):1381-91. doi: 10.1007/s40265-016-0632-x.
9
Sofosbuvir-Daclatasvir-Simeprevir Plus Ribavirin in Direct-Acting Antiviral-Experienced Patients With Hepatitis C.索磷布韦-达拉他韦-西美瑞韦联合利巴韦林治疗慢性丙型肝炎直接作用抗病毒药物治疗经验患者。
Clin Infect Dis. 2017 Jun 1;64(11):1615-1618. doi: 10.1093/cid/cix214.
10
A Closing Chapter: Hepatitis C Genotype 3 Elimination in Liver Transplant; Sofosbuvir/Daclatasvir in a Hard-to-Treat Population.终章：肝移植中丙型肝炎病毒3型的消除；索磷布韦/达卡他韦在难治性人群中的应用
Exp Clin Transplant. 2018 Feb;16(1):61-67. doi: 10.6002/ect.2016.0296. Epub 2017 Nov 15.
Zotero 插件